Cargando…
Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases
BACKGROUND: To understand the contribution of Mendelian mutations to the burden of undiagnosed diseases that are suspected to be genetic in origin, we developed a next-generation sequencing-based multiplexing assay that encompasses the ~3000 known Mendelian genes. This assay, which we term the Mende...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499193/ https://www.ncbi.nlm.nih.gov/pubmed/26112015 http://dx.doi.org/10.1186/s13059-015-0693-2 |